Novavax
NVAX
#5727
Rank
NZ$2.32 B
Marketcap
NZ$14.07
Share price
-3.02%
Change (1 day)
24.59%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): NZ-$2.63

According to Novavax's latest financial reports the company's current EPS (TTM) is NZ-$2.77. In 2025 the company made an earnings per share (EPS) of NZ$4.99 an increase over its 2024 EPS that were of NZ-$2.24.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$2.63-152.77%
2025NZ$4.99-322.76%
2024NZ-$2.24
2022NZ-$15.13-64.36%
2021NZ-$42.44243%
2020NZ-$12.3719.75%
2019NZ-$10.33-43.86%
2018NZ-$18.41-19.84%
2017NZ-$22.96-38.83%
2016NZ-$37.5474.58%
2015NZ-$21.5063.89%
2014NZ-$13.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.57-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.29-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.98-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$5.24-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ-$4.79 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ-$7.93 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$3.68-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ-$0.80-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$2.46-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ-$9.18 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA